Recent updates on the role of phytochemicals in the treatment of glioblastoma multiforme

Author:

Sharma Pramita1,Mondal Himel2,Mondal Shaikat3,Majumder Rabindranath4

Affiliation:

1. Department of Zoology, The University of Burdwan, Burdwan, West Bengal, India

2. Department of Physiology, All India Institute of Medical Sciences, Deoghar, Jharkhand, India

3. Department of Physiology, Raiganj Government Medical College, Raiganj, West Bengal, India

4. Centre of Healthcare Science and Technology, Indian Institute of Engineering Science and Technology, Shibpur, Howrah, West Bengal, India

Abstract

ABSTRACTS Glioblastoma multiforme (GBM) is a malignant type of glioma. This malignant brain tumor is a devastating disease and is often fatal. The spectrum of illness and poor prognosis associated with brain tumors extract a terrible toll on patients and their families. The inoperability of these tumors and resistance to radiation and chemotherapy contribute to the fatal outcome of this disease. Thus, scientists are hunting for the new drug candidate and safer chemoprevention, especially the phytochemicals that possess potent anti-tumor properties. We have summarized the cellular and biochemical impacts of different phytochemicals that can successfully encounter GBM via induction of apoptosis and active interference in different cell and molecular pathways associated with GBM in brain tumors. The in silico predictive model determining the blood–brain barrier permeability of the compound and their potential druggability are discussed in the review.

Publisher

Medknow

Reference88 articles.

1. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015;Ostrom;Neuro Oncol,2018

2. Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment;Hanif;Asian Pac J Cancer Prev,2017

3. Cytokines in clinical cancer immunotherapy;Berraondo;Br J Cancer,2019

4. Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: Current status and future outlook;Wu;Cancer J,2012

5. Temozolomide and other alkylating agents in glioblastoma therapy;Strobel;Biomedicines,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3